DJO Global, Inc. ("DJO" or the "Company"), a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that it has signed an exclusive distribution agreement with Exos Corporation, providing DJO with exclusive rights to sell Exos' broad range of upper extremity products that incorporate Exos' thermoformable polymer technology in North and South America. Terms of the distribution agreement were not disclosed. The agreement commences October 1, 2011.
“Exos' unique technology will enable DJO to market their next generation of upper extremity bracing and supports products now, while providing us with an impressive array of future opportunities.”
Based in Arden Hills, MN, Exos Corporation is a medical device company focused on a revolutionary thermoformable external musculoskeletal stabilization system. The company has filed several U.S. patents for the application, materials and construction of its products and is continuously adding to its intellectual property portfolio.
Exos is the only thermoformable bracing system, offering a waterproof, removable, adjustable and reformable solution for the treatment of fractures and other injuries requiring stabilization. This innovative technology has the opportunity to dramatically change clinical practices for external musculoskeletal support and stabilization.
"It has always been DJO's passion to identify innovative solutions to improve patient outcomes while controlling overall healthcare costs," said Mike Mogul, president and chief executive officer of DJO Global. "Exos' unique technology will enable DJO to market their next generation of upper extremity bracing and supports products now, while providing us with an impressive array of future opportunities."
Study reveals nerve changes linked to pain and urinary frequency in recurrent UTI sufferers